13 July 2012

Prevention of overdiagnosis: literature

References to the article
“Preventing overdiagnosis: how to stop harming the healthy”Abramson J. Overdosed America: the broken promise of American medicine.

  1. Harper, 2004.
  2. Brownlee S. Overtreated: why too much medicine is making us sicker and poorer Bloomsbury, 2007.
  3. Welch G, Schwartz L, Woloshin S. Overdiagnosed: making people sick in pursuit of health. Beacon Press, 2011.
  4. Jorgensen K, Gotzsche P. Overdiagnosis in publicly organised mammography screening programmes: systematic review of incidence trends. BMJ 2009;339:b2587.
  5. Black W. Advances in radiology and the real versus apparent effects of early diagnosis. Eur J Radiol 1998;27:116–22.
  6. Moynihan R, Heath I, Henry D. Selling sickness: the pharmaceutical industry and disease-mongering. BMJ 2002;324:886-91.
  7. Berwick D, Hackbarth, A. Eliminating waste in US health care. JAMA 2012;307:1513-6.
  8. Moynihan R, Cassels A. Selling sickness: how the world’s biggest pharmaceutical companies are turning us all into patients. Nation Books, 2005.
  9. Grady D, Redberg R. Less is more: how less health care can result in better health. Arch Intern Med 2010;170:749-50.
  10. European Health Forum Gastein. Innovation and wellbeing: living longer – but are we living better? Press release, 8 September 2011. www.ehfg.org/826.html#c1950.
  11. Choosing Wisely. US physician groups identify commonly used tests or procedures they say are often not necessary. Press release, 4 April 2012.
  12. Welch G, Black W. Overdiagnosis in cancer. JNCI 2010;102:605-13.
  13. Lauer M. Pseudodisease, the next great epidemic in coronary atherosclerosis? Arch Intern Med 2011;171:1268-9.
  14. Woolfe S, Harris R. The harms of screening. JAMA 2012;307:565-6.
  15. Orme NM, Fletcher JG, Siddiki HA, Harmsen WS, O’Byrne MM, Port JD, et al. Incidental findings in imaging research: evaluating incidence, benefit, and burden. Arch Intern Med 2010;170:1525-32.
  16. Schwartz LM, Woloshin S. Changing disease definitions: implications for disease prevalence: analysis of the third national health and nutrition examination survey, 1988–1994. Effect Clin Pract 1999;2:76-85.
  17. Kaplan R, Ong M. Rationale and public health implications of changing CHD risk factor definitions. Annu Rev Public Health 2007;28:321-44.
  18. Herndon MB, Schwartz LM, Woloshin S, Welch G. Implications of expanding disease definitions: the case of osteoporosis. Health Aff 2007;26:1702-11.
  19. Moynihan R. Merging of marketing and medical science: female sexual dysfunction. BMJ 2010;341:c5050.
  20. Moynihan, R. A new deal on disease definition. BMJ 2011;342:d2548
  21. Ahmed A, Blake G, Rymer J, Fogelman I. Screening for osteopenia and osteoporosis: do the accepted normal ranges lead to overdiagnosis? Osteoporos Int 1997;7:432-8.
  22. Hodgkinson J, Mant J, Martin U, Guo B, Hobbs F, Deeks J, et al. Relative effectiveness of clinic and home blood pressure monitoring compared with ambulatory blood pressure monitoring in diagnosis of hypertension: systematic review. BMJ 2011;342:d3621.
  23. Winearls C, Glassock R. Classification of chronic kidney disease in the elderly: pitfalls and errors. Nephron Clin Pract 2011;119(suppl 1):c2-4.
  24. Biesheuvel C, Barratt A, Howard K, Houssami N, Irwig L. Effects of study methods and biases on estimates of invasive breast cancer overdetection with mammography screening: a systematic review. Lancet Oncol 2007;8:1129-38.
  25. Morrell S, Barratt A, Irwig L, Howard K, Biesheuvel C, Armstrong B. Estimates of overdiagnosis of invasive breast cancer associated with screening mammography Cancer Causes Control 2010;21:275-82.
  26. Kalager M, Adami H, Bretthauer M, Tamimi R. Overdiagnosis of invasive breast cancer due to mammography screening: results from the Norwegian screening program. Ann Intern Med 2012;156:491-9.
  27. Tan G, Gharib H. Thyroid incidentalomas: management approaches to nonpalpable nodules discovered incidentally on thyroid imaging. Ann Intern Med 1997;126:226-31.
  28. Davies L, Welch G. Increasing incidence of thyroid cancer in the United States, 1973-2002. JAMA 2006;295:2164-7.
  29. International Association of Diabetes and Pregnancy Study Groups. Recommendations on the diagnosis and classification of hyperglycemia in pregnancy. Diabetes Care 2010;33:676-82.
  30. Ryan E. Diagnosing gestational diabetes. Diabetologia 2011;54:480-6.
  31. Cundy T. Proposed new diagnostic criteria for gestational diabetes—a pause for thought? Diabet Med 2012;29:176-80.
  32. Levey AS, Stevens LA, Schmid CH, Zhang YL, Castro AF 3rd, Feldman HI, et al. A new equation to estimate glomerular filtration rate. Ann Intern Med 2009;150:604-12.
  33. National Kidney Foundation. Clinical practice guidelines for chronic kidney disease: evaluation, classification and stratification. Am J Kidney Dis 2002;39(suppl 1):s17-31.
  34. Glassock R. Estimated glomerular filtration rate: time for a performance review? Kidney Int 2009;75:1001-3.
  35. Winearls C, Haynes, R, Glassock R. CKD staging—evolution not revolution. Nefrologia 2010;30:493-500.
  36. Eknoyan G. Chronic kidney disease definition and classification: the quest for refinements. Kidney Int 2007;72:1183-5.
  37. Aaron S, Vandemheen K, Boulet L, McIvor R, FitzGerald J, Hernandez P, et al. Overdiagnosis of asthma in obese and nonobese adults. CMAJ 2008;179:1121-31.
  38. Lucas A, Smeenk F, Smeele I, van Schayck C. Overtreatment with inhaled corticosteroids and diagnostic problems in primary care patients, an exploratory study. Fam Pract 2008;25:86-91.
  39. Prasad V, Rho J, Cifu A. The diagnosis and treatment of pulmonary embolism. Arch Intern Med 2012 Apr [Epub ahead of print].
  40. Weiner R, Schwartz LM, Woloshin S. Time trends in pulmonary embolism in the United States. Arch Intern Med 2011;171:831-7.
  41. Carrier M. A study to evaluate the safety of withholding anticoagulation in patients with subsegmental PE who have a negative serial bilateral lower extremity ultrasound (SSPE). 2011.
  42. Angell M. The epidemic of mental illness: why? New York Review Books 2011 Jun 23.
  43. Frances A. The first draft of DSM-V. BMJ 2010;340:c1168.
  44. Healy D. The latest mania: selling bipolar disorder. PLoS Med 2006;3:e185.
  45. Thomas R. The diagnostic variability in attention deficit hyperactivity disorder. Presentation to Overdiagnosis Meeting, Coolangatta, 29-30 April 2012.
  46. Morrow R, Garland E, Wright J, Maclure M, Taylor S, Dormuth C. Influence of relative age on diagnosis and treatment of attention-deficit/hyperactivity disorder in children. CMAJ 2012;184:755-62.
  47. Heath I, Hippisley-Cox J, Smeeth L. Measuring performance and missing the point. BMJ 2007;335;1075-6.
  48. Greene J. Prescribing by numbers; drugs and the definition of disease. Johns Hopkins University Press, 2007.
  49. Fenton J, Jerant A, Bertakis K, Franks P. The cost of satisfaction. Arch Intern Med 2012;172:405-11.
  50. Fisher ES, Wennberg DE, Stukel TA, Gottlieb DJ, Lucas FL, Pinder EL. The implications of regional variations in Medicare spending, part 2: health outcomes and satisfaction with care. Ann Intern Med 2003;138:288-98.
  51. Kramer B. Current and future perspectives on cancer prevention research. National Cancer Advisory Board, 2012.
  52. Schwartz L, Woloshin S, Fowler F, Welch G. Enthusiasm for cancer screening in the United States. JAMA 2004;291:71-8.
  53. Elmore J, Fletcher S. Overdiagnosis in breast cancer screening: time to tackle an underappreciated harm. Ann Intern Med 2012;156:536-7.
  54. Taylor B, Wilt T, Welch G. Impact of diastolic and systolic blood pressure on mortality: implications for the definition of “normal”. J Gen Intern Med 2011;26:685-90.
  55. Prasad V, Cifu A, Ioannidis J. Reversals of established medical practices. JAMA 2012;307:37-8.
  56. Reich J. A critical appraisal of overdiagnosis: estimates of its magnitude and implications for lung cancer screening. Thorax 2008;63:377-83.

Portal "Eternal youth" http://vechnayamolodost.ru13.07.2012

Found a typo? Select it and press ctrl + enter Print version